Home » Vertex Pharmaceuticals Announces Pricing of Common Stock Offering
Vertex Pharmaceuticals Announces Pricing of Common Stock Offering
June 8, 2005
Vertex Pharmaceuticals Incorporated announced the pricing of its public offering of 11,750,000 shares of its common stock at a price of $13.00 per share. The gross proceeds, before commissions and expenses, of the public offering will be approximately $152.8 million. All of the shares are being offered by Vertex. The company has also granted the underwriters a 30-day option to purchase up to an additional 1,762,500 shares to cover over-allotments.
()a href="http://www.newswire.ca/en/releases/archive/June2005/07/c9008.html" target="_blank">Canada NewsWire Group
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct